Clinical characteristics and presence of prolactinoma in women with hyperprolactinemia

被引:0
|
作者
Alberto Lopez-Clavijo, Carlos [1 ,2 ,3 ,4 ]
Esteban Gaviria-Maya, Juan [5 ]
Eduardo Henao-Florez, Rodrigo [2 ]
Leandro Piedrahita-Gutierrez, Dany [3 ,6 ]
机构
[1] InSer Pereira, Pereira, Colombia
[2] Univ Caldas, Ginecol & Obstet, Manizales, Colombia
[3] Fdn Univ Autonoma Amer, Medellin, Colombia
[4] Univ Tecnol Pereira, Biol Mol & Biotecnol, Pereira, Colombia
[5] Univ Caldas, Manizales, Colombia
[6] InSer Pereira, Endocrinol Reprod Humana & Infertilidad, Pereira, Colombia
关键词
Amenorrhea; Galactorrhea; Hyperprolactinemia; Infertility; Magnetic Resonance Imaging; Prolactin; Prolactinoma;
D O I
10.17533/udea.iatreia.v29n3a04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To clinically characterize women with hyperprolactinemia at InSer Pereira (Colombia) and to determine the prevalence of prolactinoma. Methods: Retrospective description of 45 patients with hyperprolactinemia, and contrasted pituitary magnetic resonance (MR), between January 2008 and July 2013. Clinical manifestations, etiology, serum prolactin level, and MR findings were included. Results: The most frequent clinical manifestations were: infertility, galactorrhea, oligomenorrhea. There were 26 cases of prolactinoma (57.8 %), and 12 of idiopathic hyperprolactinemia (26.6 %). Out of the 26 prolactinomas, 23 were microadenomas (average size 5.1 mm; SD +/- 3.2 mm). Average serum prolactin level was 74.05 ng/mL (SD +/- 13.33 ng/mL). 78 % of patients with prolactinoma had serum prolactin level under 70.0 ng/mL. No significant association was found between serum prolactin level and the presence of prolactinoma. Conclusion: Prolactinomas are the main cause of hyperprolactinemia and they are found mostly with slight rise of serum prolactin. Pituitary MRI is recommended in patients with hyperprolactinemia, regardless of their prolactin level.
引用
收藏
页码:292 / 300
页数:9
相关论文
共 50 条
  • [21] Clinical and diagnostic characteristics of hyperprolactinemia in childhood and adolescence
    Catli, Gonul
    Abaci, Ayhan
    Bober, Ece
    Buyukgebiz, Atilla
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2013, 26 (1-2): : 1 - 11
  • [22] Hyperprolactinemia has no effect on plasma ghrelin levels in patients with prolactinoma
    Delibasi, Tuncay
    Arslan, Muyesser Sayki
    Cakal, Erman
    Sahin, Mustafa
    Topaloglu, Oya
    Tutal, Esra
    Unsal, Ilknur Ozturk
    Karbek, Basak
    Ucan, Bekir
    Gungunes, Askin
    Karakose, Melia
    Caliskan, Mustafa
    Demirci, Taner
    Tabur, Gulfer
    Ozbek, Mustafa
    JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2015, 16 (02) : 86 - 90
  • [23] Diagnostic criteria of small sellar lesions with hyperprolactinemia: Prolactinoma or else
    Cho, Anna
    Vila, Greisa
    Marik, Wolfgang
    Klotz, Sigrid
    Wolfsberger, Stefan
    Micko, Alexander
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [24] CLINICAL USE OF METOCLOPRAMIDE TEST IN THE DIAGNOSIS OF WOMEN WITH HYPERPROLACTINEMIA
    VAZQUEZMATUTE, L
    CANALES, ES
    ALGER, M
    ZARATE, A
    HORMONE RESEARCH, 1979, 10 (04) : 207 - 212
  • [25] A study of the clinical differences between women and men with hyperprolactinemia
    Ramot, Y
    Rapoport, MJ
    Hagag, P
    Wysenbeek, AJ
    GYNECOLOGICAL ENDOCRINOLOGY, 1996, 10 (06) : 397 - 400
  • [26] Hyperprolactinemia in Women
    Walch K.
    Journal für Gynäkologische Endokrinologie/Österreich, 2021, 31 (3): : 102 - 105
  • [27] HYPERPROLACTINEMIA IN WOMEN
    RUDOLF, K
    KYANK, H
    KUNKEL, S
    DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1982, 37 (21): : 953 - 956
  • [28] HYPERPROLACTINEMIA IN WOMEN
    RUDOLF, K
    KYANK, H
    KUNKEL, S
    DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1982, 37 (20): : 913 - 917
  • [29] Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment
    Raven, Lisa M.
    Guttman-Jones, Michelle
    Muir, Christopher A.
    ENDOCRINE, 2021, 72 (02) : 524 - 528
  • [30] Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment
    Lisa M. Raven
    Michelle Guttman-Jones
    Christopher A. Muir
    Endocrine, 2021, 72 : 524 - 528